8-K filed October 9, 2026, 4:54 PM ET ticker GBCS CIK 0000727346

M&A confidence high sentiment neutral materiality 1.00

Selectis Health completes merger with Black Pearl Equities II; shareholders receive $5.75 per share

SELECTIS HEALTH, INC.

On October 5, 2026, Merger Sub merged into Selectis Health, Inc.; Selectis became a wholly owned subsidiary of Black Pearl Equities II, LLC and an indirect subsidiary of Parent.
Offer price and merger consideration were $5.75 per share; 2,789,027 shares (~90.93%) tendered; aggregate cash consideration was about $17,635,589, excluding warrants and other equity awards.
The Company became a borrower under a Credit Agreement with Milrose Capital, LLC and SCG Experts Corp.; $18,226,250 term loans bear 5.0% interest and mature August 28, 2031.
Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased serving as directors; Krystal Eckhart ceased as interim CFO; Abraham Schwartz and Zalman Schapiro became directors and officers.
Selectis notified FINRA; Shares will no longer be quoted on OTCQB. It intends to file Form 15 to terminate Exchange Act registration and suspend reporting obligations.

item 2.01 item 2.03 item 1.01 item 3.03 item 5.01 item 5.02 item 5.03 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Huebner

Director

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

Appointed

Abraham Schwartz

Director

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

Appointed

Abraham Schwartz

Other Named Officer

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

Appointed

Zalman Schapiro

Director

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

Departed (interim)

Krystal Eckhart

Interim Chief Financial Officer

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

Departed

Kent J. Lund

Director

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

Appointed

Zalman Schapiro

Other Named Officer

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

Departed

Clifford L. Neuman

Director

GBCS · SELECTIS HEALTH, INC.

Effective: 2026-10-05
Filed: October 9, 2026, 4:54 PM ET

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.92

Richard Huebner departed as Director at SELECTIS HEALTH, INC..

Action: ceased to serve
Role: Director

Exact text from the filing

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Abraham Schwartz was appointed as Director at SELECTIS HEALTH, INC..

Action: became the directors
Role: Director

Exact text from the filing

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.65

Abraham Schwartz was appointed as other_named_officer at SELECTIS HEALTH, INC..

Action: became the officers

Exact text from the filing

and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Zalman Schapiro was appointed as Director at SELECTIS HEALTH, INC..

Action: became the directors
Role: Director

Exact text from the filing

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.92

Krystal Eckhart departed as Interim Chief Financial Officer at SELECTIS HEALTH, INC..

Action: ceased to serve
Role: Interim Chief Financial Officer

Exact text from the filing

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.92

Kent J. Lund departed as Director at SELECTIS HEALTH, INC..

Action: ceased to serve
Role: Director

Exact text from the filing

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.65

Zalman Schapiro was appointed as other_named_officer at SELECTIS HEALTH, INC..

Action: became the officers

Exact text from the filing

and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.92

Clifford L. Neuman departed as Director at SELECTIS HEALTH, INC..

Action: ceased to serve
Role: Director

Exact text from the filing

In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.

View on SEC.gov

SELECTIS HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-046568

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.